Vapotherm Inc. (VAPO)

Business: Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally.

IPO Date: 14-Nov-2018

CEO, Pres & Director: Mr. Joseph F. Army CPA, CPA

Sr. VP, CFO & Treasurer: Mr. John Landry

Listing: NYSE: VAPO

Country: United States

Headquarters: Exeter, NH

Website: https://www.vapotherm.com

Market cap: $83.94 Mln

Revenue (TTM): $102.61 Mln

Earnings (TTM): $-72.33 Mln

Cash: $72.91 Mln

Total Debt: $98.55 Mln

Insider's Holding: 11.02%

Liquidity: Low

52 Week range: $2.46 - 31.87

Shares outstanding: 26,563,500

6 Years Aggregate:

• CFO: $-229.08 Mln
• EBITDA: $-222.06 Mln
• Net Profit: $-258.91 Mln